Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula

Recruiting N/A Interventional Study
Tracheo-Esophageal Fistula with Atresia of Esophagus
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 1
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
20 (estimated)
Sponsor
Birmingham Women's and Children's NHS Foundation Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to look at babies having a primary or delayed primary oesophageal repair for OA with dTOF to evaluate if using Indocyanine green (ICG) and near infrared fluorescence (NIRF) can decrease the rates of anastomotic leaks and/or predict which patients they will happen in. The latter evaluation would help counsel parents and mean that further research can evaluate if other tactics can pr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Pre-operative * Diagnosis of oesophageal atresia with distal trachea-oesophageal fistula (OA/dTOF) * Plan for primary or delayed primary oesophageal anastomosis Intra-operative * Diagnosis of OA/dTOF confirmed by standard methods * Primary or delayed primary oesophageal anast…
Contacts

max pachl

01213339999

max.pachl@nhs.net

CONTACT

Sarah Hadfield

01213339999

sarah.hadfield2@nhs.net

CONTACT